Effect of amperozide on the synthesis and turnover of monoamines in rat brain.

The effects of amperozide on the synthesis and the turnover of monoamines in different brain regions of the rat were determined using both ex vivo and in vivo biochemical techniques (i.e. post-mortem measurements of the tissue levels by HPLC-EC, and direct measurements with the in vivo voltammetry technique). It was found that amperozide slightly increased the DOPA accumulation and the DOPAC content in limbic brain areas but not in the striatum. The DOPA accumulation was also slightly increased in the noradrenaline rich cortical region indicating increased synthesis of noradrenaline. Furthermore, amperozide increased the utilization of noradrenaline after tyrosine hydroxylase inhibition by alpha-methyl-p-tyrosine. The synthesis of 5-HT was not significantly altered by amperozide. In conclusion, the biochemical data obtained in this study suggest that amperozide produces preferential effects on the mesolimbic dopaminergic system. In addition, amperozide also interacts with the noradrenergic system.

[1]  G. Andersson,et al.  Wasting pig syndrome (WPS) in weaners--treatment with amperozide. , 1989, Journal of veterinary pharmacology and therapeutics.

[2]  J. Engel,et al.  Effects of amperozide in two animal models of anxiety. , 1989, Pharmacology & toxicology.

[3]  O. Olsson,et al.  Effects of amperozide on biting behavior and performance in restricted-fed pigs following regrouping. , 1988, Journal of animal science.

[4]  J. Haskins,et al.  Biochemical and electrophysiological studies of the psychotropic compound, amperozide , 1987, Brain Research Bulletin.

[5]  J. Leysen,et al.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. , 1985, Molecular pharmacology.

[6]  S. Hjorth,et al.  Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings. , 1982, European journal of pharmacology.

[7]  F. Gonon,et al.  Electrochemical treatment of pyrolytic carbon fiber electrodes , 1981 .

[8]  J. Korf,et al.  On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs. , 1977, European journal of pharmacology.

[9]  A. Carlsson,et al.  Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo , 1973, The Journal of pharmacy and pharmacology.

[10]  J. Davis,et al.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylase , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[11]  B. Gustafsson,et al.  Amperozide and emotional behaviour. , 1990, Pharmacology & toxicology.

[12]  T. Svensson,et al.  Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo. , 1990, Pharmacology & toxicology.

[13]  A. Björk,et al.  Amperozide: a new pharmacological approach in the treatment of schizophrenia. , 1990, Pharmacology & toxicology.

[14]  B. Gustafsson,et al.  Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour. , 1990, Pharmacology & toxicology.

[15]  P. Simonsson,et al.  Receptor binding properties of amperozide. , 1990, Pharmacology & toxicology.

[16]  K. Svensson.  Dopamine autoreceptor antagonists : a new class of central stimulants , 1986 .

[17]  P. Waldmeier,et al.  Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test. , 1985, Biochemical pharmacology.